Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Prytime Medical
Boerne, Texas, United States
- Ownership
- Private
- Employees
- ~32
- Development stage
- Other
01
Overview
Prytime Medical develops and commercializes minimally invasive endovascular balloon occlusion catheters (REBOA) such as ER-REBOA and pREBOA-PRO for rapid, temporary aortic occlusion to control life‑threatening hemorrhage in emergency, critical care, and battlefield settings; these devices have FDA 510(k) clearance and are in routine clinical use in hundreds of hospitals worldwide.[2][5]
- Therapeutic areas
- HematologyCardiovascularWomen's Health
- Modalities
- DeviceNon-pharmacological therapy
- Industry
- Surgical Medical Devices
02
Partnerships
U.S. Army Medical Research and Development Command (FORCE study on partial REBOA in battlefield conditions).[5]
Beyond the preview
Go deeper on Prytime Medical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Prytime Medical.